Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, B-Cell × Everolimus × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Carcinoma, Renal Cell 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 4 Tuberous Sclerosis 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thymus Neoplasms 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Pheochromocytoma 1 Phase IB 1 Paraganglioma 1 Ovarian Neoplasms 1 Nevus 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphoma 1

Interventions

Cyclophosphamide 5 fludarabine phosphate 3 fludarabine 3 Mycophenolic Acid 3 Mesna 3 Melphalan 3 ibrutinib 2 acalabrutinib 2 Whole-Body Irradiation 2 Tacrolimus 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Busulfan 2 Bone Marrow Transplantation 2 ricolinostat 1 pirtobrutinib 1 obinutuzumab 1 idelalisib 1 idecabtagene vicleucel 1 Vincristine 1 Stem Cell Transplantation 1 Prednisone 1 Leukapheresis 1 Filgrastim 1 Doxorubicin 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡